Raludotatug Deruxtecan Promising in Platinum-Resistant Advanced Ovarian Cancer
SAN DIEGO — Treatment with raludotatug deruxtecan (R-DXd) led to an “exciting” response rate among patients with heavily pretreated, platinum-resistant advanced ovarian cancer, according to an early-phase trial. In a subgroup analysis of the first-in-human phase I study, there was one complete response and 17 partial responses among 37 evaluable patients treated with R-DXd, an […]
Match Day 2023: Five Debt Management Tips for New Doctors
Match Day is an exciting yet stressful time for new doctors. One of the more stressful things is that you’re now transitioning from a debt accumulation stage to a sort of stalled-out debt payment stage. This is really the first time young doctors need to start planning and thinking about their debt. Here are some […]